Cargando…

Assessment of metabolic and mitochondrial dynamics in CD4+ and CD8+ T cells in virologically suppressed HIV-positive individuals on combination antiretroviral therapy

Metabolism plays a fundamental role in supporting the growth, proliferation and effector functions of T cells. We investigated the impact of HIV infection on key processes that regulate glucose uptake and mitochondrial biogenesis in subpopulations of CD4+ and CD8+ T cells from 18 virologically-suppr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masson, Jesse J. R., Murphy, Andrew J., Lee, Man K. S., Ostrowski, Matias, Crowe, Suzanne M., Palmer, Clovis S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576743/ https://www.ncbi.nlm.nih.gov/pubmed/28854263 http://dx.doi.org/10.1371/journal.pone.0183931

Ejemplares similares

Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1–Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy
por: Gras, Luuk, et al.
Publicado: (2019)

Polymorphism rs1385129 Within Glut1 Gene SLC2A1 Is Linked to Poor CD4+ T Cell Recovery in Antiretroviral-Treated HIV+ Individuals
por: Masson, Jesse J. R., et al.
Publicado: (2018)

A Bioelectronic System to Measure the Glycolytic Metabolism of Activated CD4+ T Cells
por: Crowe, Suzanne M., et al.
Publicado: (2019)

Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy
por: Ku, Nam Su, et al.
Publicado: (2016)

CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta-analysis
por: Ford, Nathan, et al.
Publicado: (2015)

Glucose Metabolism Regulates T Cell Activation, Differentiation, and Functions
por: Palmer, Clovis S., et al.
Publicado: (2015)

Quantitative Assessment of Intra-Patient Variation in CD4+ T Cell Counts in Stable, Virologically-Suppressed, HIV-Infected Subjects
por: Gordon, Claire L., et al.
Publicado: (2015)

CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapy
por: Aldrete, Sol, et al.
Publicado: (2020)

Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy
por: Prabhakar, B., et al.
Publicado: (2011)

Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment
por: Briceño, Olivia, et al.
Publicado: (2016)

Comparative Impact of Suppressive Antiretroviral Regimens on the CD4/CD8 T-Cell Ratio: A Cohort Study
por: Masiá, Mar, et al.
Publicado: (2016)

Antiretroviral adherence and virologic suppression in partnered and unpartnered HIV-positive individuals in southern Brazil
por: de Melo, Marineide Gonçalves, et al.
Publicado: (2019)

Predictors of suboptimal CD4 response among women achieving virologic suppression in a randomized antiretroviral treatment trial, Africa
por: Asmelash, Aida, et al.
Publicado: (2014)

Metabolically active CD4+ T cells expressing Glut1 and OX40 preferentially harbor HIV during in vitro infection
por: Palmer, Clovis S., et al.
Publicado: (2017)

Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2017)

Combination anti‐HIV antibodies to achieve antiretroviral therapy‐free virological suppression in infected individuals
por: Rai, M. Ali, et al.
Publicado: (2022)

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
por: Trickey, Adam, et al.
Publicado: (2017)

Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers
por: Chereau, Fanny, et al.
Publicado: (2017)

Induction of HIF-1α by HIV-1 Infection in CD4(+) T Cells Promotes Viral Replication and Drives Extracellular Vesicle-Mediated Inflammation
por: Duette, Gabriel, et al.
Publicado: (2018)

CD161(+) CD4(+) T Cells Harbor Clonally Expanded Replication-Competent HIV-1 in Antiretroviral Therapy-Suppressed Individuals
por: Li, Xiaomin, et al.
Publicado: (2019)

CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study
por: Chammartin, Frédérique, et al.
Publicado: (2022)

Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India
por: Dravid, Ameet N., et al.
Publicado: (2018)

978. Changes in BMI Associated with Antiretroviral Regimens in Treatment-Experienced, Virologically Suppressed Individuals Living with HIV
por: Mounzer, Karam, et al.
Publicado: (2019)

CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients
por: Lu, Wei, et al.
Publicado: (2015)

Perturbed CD8(+) T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals
por: Tauriainen, Johanna, et al.
Publicado: (2017)

Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation
por: Jose, S, et al.
Publicado: (2015)

Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1
por: Peluso, Michael J, et al.
Publicado: (2020)

Higher CD27(+)CD8(+) T Cells Percentages during Suppressive Antiretroviral Therapy Predict Greater Subsequent CD4(+) T Cell Recovery in Treated HIV Infection
por: Seu, Lillian, et al.
Publicado: (2013)

HIV DNA positively correlates with HLA-DR+CD8+ T lymphocytes over 8-year suppressive antiretroviral therapy
por: Zhu, Tianyuan, et al.
Publicado: (2023)

Human Herpesvirus Replication and Abnormal CD8+ T Cell Activation and Low CD4+ T Cell Counts in Antiretroviral-Suppressed HIV-Infected Patients
por: Jacobson, Mark A., et al.
Publicado: (2009)

Harnessing CD8(+) T Cells Under HIV Antiretroviral Therapy
por: Warren, Joanna A., et al.
Publicado: (2019)

CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV
por: Han, Win Min, et al.
Publicado: (2018)

Modifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients
por: Collins, Sean E., et al.
Publicado: (2015)

Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failure
por: Schultze, Anna, et al.
Publicado: (2014)

2072. Of Mice and Men: HIV-induced CD38 expression on CD8+ T lymphocytes contributes to mitochondrial dysfunction and chronic inflammation despite antiretroviral therapy
por: Mathur, Poonam, et al.
Publicado: (2022)

Transcriptional Changes in CD8(+) T Cells During Antiretroviral Therapy Intensified With Raltegravir
por: Ouyang, Zhengyu, et al.
Publicado: (2015)

The CD4:CD8 ratio is associated with IMT progression in HIV-infected patients on antiretroviral treatment
por: Bernal, Enrique, et al.
Publicado: (2014)

Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection
por: Thornhill, John, et al.
Publicado: (2014)

How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy
por: Jaworowski, Anthony, et al.
Publicado: (2019)

Mitochondrial superoxide disrupts the metabolic and epigenetic landscape of CD4(+) and CD8(+) T-lymphocytes
por: Moshfegh, C.M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6h2ls34gplk66t7v9ps9o7vdto